Starting October 1, UnitedHealthcare will remove prior-authorization requirements across cardiology, lab testing, therapy and selected musculoskeletal services.
UnitedHealth Group (NYSE:UNH), the health-insurance and care-delivery giant, rose roughly 1.4% to $394.745 in Tuesday morning trading after announcing another major rollback of administrative requirements. Beginning October 1, UnitedHealthcare will drop prior-authorization requirements across cardiology, laboratory testing, therapy and selected musculoskeletal services.
The changes span commercial insurance, Medicare Advantage and individual Affordable Care Act plans. UnitedHealthcare aims to remove prior authorization from 30% of services by year-end and to accelerate payments by as much as 50% for roughly 1,400 rural hospitals.
The company's second-quarter results produced $112 billion in revenue, $8 billion in operating earnings and a 4.9% net margin. Reduced bureaucracy could cut costs and ease strained relationships with patients and providers, though fewer approval checks may also push medical utilization higher.
With net margins below 5%, there is limited room for error. Markets move, and future claims data will determine whether the recent gains hold — past results do not guarantee future outcomes.
Newsletter
Markets in your inbox, weekly
Latin America-focused analysis, investment themes and the week in finance.
